// App-Quantinova.ai

: EFFICACY OF CONSOLIDATION CHEMOTHERAPY FOR PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA WHO ACHIEVED COMPLETE REMISSION BY FIRST COURSE OF REMISSION INDUCTION THERAPY.

Researchers

Presenter

  • Akio Shigematsu

Principal Investigators

  • Ryoji Kobayashi

  • Takeshi Kondo

  • Tomoyuki Endo

  • Yutaka Tsutsumi

  • Hajime Kobayashi

  • Yasukata Kakinoki

  • Satoshi Yamamoto

  • Yuichi Konuma

  • Takuto Miyagishima

  • Tetsuyuki Igarashi

  • Takanori Oda

  • Hajime Sakai

  • Toshimichi Ishihara

  • Masahiro Yoshida

  • Takahiro Nagashima

  • Kazuya Sato

  • Yuji Kanisawa

  • Toshihito Haseyama

  • Yasuo Hirayama

  • Mitsutoshi Kurosawa

Medical Centers

  • Department of Gastroenterology, Sapporo Hokuyu Hospital, Sapporo, Japan

  • Department of Gastroenterology, Sapporo Hokuyu Hospital, Sapporo, Japan

  • Sapporo Hokuyu Hospital, Sapporo, Japan

  • Blood Disorders Center, Department of Hematology,Aiiku Hospital,Sapporo,Japan

  • Department of Radiology, Okayama University Graduate School of Medicine, Okayama, Japan

  • Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Japan

  • Department of Gastroenterology, Obihiro Kyokai Hospital, Obihiro, Japan

  • Department of Surgery, Asahikawa City Hospital, Asahikawa, Japan

  • Department of Surgery, Sapporo City General Hospital, Sapporo, Japan

  • Department of Hematology/Oncology,Asahikawa Red Cross Hospital,Asahikawa,Japan

  • Department of Medical Oncology, Kushiro Rosai Hospital, Kushiro, Japan

  • Department of Hematology, Tenshi Hospital, Sapporo, Japan

  • Department of Pediatrics, Hokkaido Medical Center for Child Health and Rehabilitation, Sapporo, Japan

  • Department of Medical Oncology, Keiyukai Sapporo Hospital, Sapporo, Japan

  • Department of Hematology,Kin-ikyo Chuo Hospital,Sapporo,Japan

  • Department of Gastroenterology and Clinical Oncology, Steel Memorial Muroran Hospital, Muroran, Japan

  • Department of Internal medicine,Japanese Red Cross Kitami Hospital,Kitami,Japan

  • Department of Hematology/Oncology,Asahikawa Red Cross Hospital,Asahikawa,Japan

  • Department of Hematology/Oncology,Oji General Hospital,Tomakomai,Japan

  • Department of Hematology, Tenshi Hospital, Sapporo, Japan

  • Department of Internal Medicine,Higashi Sapporo Hospital,Sapporo,Japan

  • Department of Thoracic Surgery, National Hospital Organization, Hokkaido Cancer Center, Hokkaido, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Lymphomas

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A